No Data
No Data
RadNet's (NASDAQ:RDNT) Investors Will Be Pleased With Their Solid 240% Return Over the Last Five Years
RadNet, Inc. Announces Date of Its First Quarter 2025 Financial Results Conference Call
RadNet's ICAD Deal to Expand Its Digital Health Services and Geographic Presence, Truist Says
Truist Financial Maintains RadNet(RDNT.US) With Buy Rating
Analysts' Top Healthcare Picks: Radnet (RDNT), Immunic (IMUX)
Top Premarket Gainers